Results 91 to 100 of about 14,948 (182)

Neuroprotective effects of hesperidin and auraptene on 6-hydroxydopamine-induced neurodegeneration in SH-SY5Y cells. [PDF]

Avicenna J Phytomed
Mehrparvar Tajoddini M, Gheybi E, Rostami M, Mousavi SH, Hashemy SI, Rashidi R, Soukhtanloo M.   +6 more
europepmc   +1 more source

The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy. [PDF]

Brain Sci, 2023
Rodríguez-Carreiro S, Navarro E, Muñoz E, Fernández-Ruiz J.   +3 more
europepmc   +1 more source

SKF-38393 regulates the expression of glutamic acid decarboxylase 67 via heparanase-1 in 6-hydroxydopamine-induced neurodegeneration. [PDF]

Sci Rep
Lee S, Kim M, Sung SE, Kim G, Won C.
europepmc   +1 more source

Nano-hesperetin ameliorates 6-hydroxydopamine-induced behavioral deficits and oxidative damage by up-regulating gene expression of antioxidant enzymes. [PDF]

Avicenna J Phytomed, 2023
Hajizadeh Moghaddam A, Alizadeh S, Nejadi M, Mokhtari Sangdehi SR, Zare M, Ranjbar M.   +5 more
europepmc   +1 more source

Hyperglycemia Aggravates 6-Hydroxydopamine-Induced Neuronal Ferroptosis via SLC7A11-Dependent Pathway in Diabetic PD Rat Model. [PDF]

CNS Neurosci Ther
Zhao Y, Wang D, Wang Y, Mu D, Qu L, Li R.   +5 more
europepmc   +1 more source

Longitudinal assessment of motor function following the unilateral intrastriatal 6-hydroxydopamine lesion model in mice. [PDF]

Front Behav Neurosci, 2022
Sun X, Li X, Zhang L, Zhang Y, Qi X, Wang S, Qin C.   +6 more
europepmc   +1 more source

Potentiation of leptazol seizures by 6-hydroxydopamine

Journal of Pharmacy and Pharmacology, 1973
M E, Corcoran, H C, Fibiger, E G, McGeer, J A, Wada   +3 more
openaire   +2 more sources

RETRACTION: Echinacoside Protects Against 6-Hydroxydopamine-Induced Mitochondrial Dysfunction and Inflammatory Responses in PC12 Cells via Reducing ROS Production. [PDF]

Evid Based Complement Alternat Med
And Alternative Medicine EC.
europepmc   +1 more source

N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson's Disease Rat Model. [PDF]

Antioxidants (Basel), 2023
Caridade-Silva R, Araújo B, Martins-Macedo J, Teixeira FG.   +3 more
europepmc   +1 more source

Expression of Galectin 3 and Activating Transcription Factor 3 in Nigral Dopaminergic Neurons of 6-Hydroxydopamine Induced Parkinsonian Rat Model. [PDF]

In Vivo
Lee EJ, Choy YJ, Woo RS, Baik TK, Yoo HI, Song DY.   +5 more
europepmc   +1 more source